Indivior ( (INDV) ) just unveiled an update.
Indivior PLC announced that as of May 1, 2025, its issued share capital comprises 124,769,533 Ordinary Shares, each valued at US$0.50. The total number of voting rights in the company is 124,769,533, which shareholders can use to assess their interests in accordance with FCA’s Disclosure Guidance and Transparency Rules.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and its co-occurring disorders. The company is known for its innovative approach to addressing addiction, a significant public health challenge.
YTD Price Performance: -16.89%
Average Trading Volume: 387,369
Technical Sentiment Signal: Buy
Current Market Cap: £1.08B
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.